Landaas & Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Hold
3,794
0.07% 96
2026
Q1
$272K Hold
3,794
0.06% 101
2025
Q4
$301K Hold
3,794
0.07% 94
2025
Q3
$286K Hold
3,794
0.07% 89
2025
Q2
$262K Buy
+3,794
New +$249K 0.06% 92
2018
Q3
Sell
-577
Closed -$37K 117
2018
Q2
$37K Buy
+577
New +$38K 0.03% 177
2018
Q1
Sell
-302
Closed -$22K 111
2017
Q4
$22K Hold
302
0.02% 210
2017
Q3
$25K Buy
+302
New +$23.9K 0.02% 197

Other funds holding CVS

Landaas & Company's CVS Position: Q2 2026 in Review

Landaas & Company held its CVS Health (CVS) position steady in Q2 2026 at 3,794 shares worth $392K. The position accounts for 0.07% of the portfolio, ranked #96.

Landaas & Company first reported a position in CVS in Q3 2017 and has held it in 8 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Landaas & Company held 3,794 shares of CVS Health worth $392K as of Q2 2026.
  • Landaas & Company left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.07% of Landaas & Company's portfolio in Q2 2026, its #96 holding.
  • Landaas & Company first reported a position in CVS Health in Q3 2017 and has held it in 8 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Landaas & Company's 13F filing for Q2 2026, filed 21 Jul 2026.